Exact Sciences
EXAS
#1854
Rank
$8.83 B
Marketcap
$47.55
Share price
0.30%
Change (1 day)
-19.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -$1.02 Billion USD

According to Exact Sciences's latest financial reports the company's current earnings are $2.75 Billion USD. a decrease over its 2023 earnings that were of -$0.19 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -$1.02 Billion435.08%
2023 -$0.19 Billion-69.28%
2022 -$0.62 Billion-25.55%
2021 -$0.83 Billion1.68%
2020 -$0.82 Billion271.17%
2019 -$0.22 Billion58.99%
2018 -$0.14 Billion20.89%
2017 -$0.12 Billion-30.95%
2016 -$0.17 Billion5.09%
2015 -$0.16 Billion57.24%
2014 -$0.11 Billion116.53%
2013 -$46.3 Million
2011 -$28.83 Million143.73%
2010 -$11.83 Million27.85%
2009 -$9.25 Million0.27%
2008 -$9.23 Million-20.95%
2007 -$11.67 Million-13.53%
2006 -$13.5 Million-10.07%
2005 -$15.01 Million-21.81%
2004 -$19.2 Million-33.44%
2003 -$28.84 Million-6.51%
2002 -$30.85 Million17.95%
2001 -$26.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.12 Billion-88.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$65.88 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.17 Million-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$34.97 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.94 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France